This inventor holds 1 USPTO granted patent. Top assignee: Samyang Genex Corporation. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations of Jae-Ho Lee in Cancer Diagnosis
Introduction
Jae-Ho Lee is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of cancer research through his innovative work on the SYG972 gene. His research focuses on the diagnosis and treatment of cancer, particularly breast cancer, where he has identified critical genetic markers.
Latest Patents
Jae-Ho Lee holds a patent for the "Cell growth inhibiting and cell differentiation specific SYG972 gene, genomic DNA and promoter thereof." This invention relates to a method for diagnosing cancer using the SYG972 gene. The expression of the SYG972 gene is significantly reduced in breast cancer cells compared to normal breast cells. This discovery provides a valuable tool for cancer diagnosis, utilizing the gene or its fragments as a probe. The SYG972 genomic DNA consists of 4 exons and 3 introns, with a promoter that is 3 kb long from the transcription initiating site in the 5' direction. This genomic DNA and promoter can be instrumental in designing and screening drugs aimed at promoting or inhibiting apoptosis and differentiation of cells, particularly in cancer treatment.
Career Highlights
Jae-Ho Lee is associated with Samyang Genex Corporation, where he continues to advance his research in genetics and cancer treatment. His work has garnered attention for its potential applications in the medical field, particularly in developing targeted therapies for cancer patients.
Collaborations
Jae-Ho Lee has collaborated with notable colleagues, including Neon-Cheol Jung and Jin-Man Kim. Their combined expertise enhances the research efforts at Samyang Genex Corporation, contributing to innovative solutions in cancer diagnosis and treatment.
Conclusion
Jae-Ho Lee's contributions to cancer research through his patented innovations highlight the importance of genetic studies in developing diagnostic tools and therapies. His work exemplifies the potential of scientific research to impact healthcare positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile